Modification of the p62 promoter by oxidation is correlated with Alzheimer's disease, Huntington's disease, and Parkinson's disease among other neurodegenerative disorders.
A modificación do promotor de p62 por oxidación está correlacionada coa enfermidade de Alzheimer, e coas de Huntington, e Parkinson entre outros trastornos neurodexenerativos.